Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMIM11P1 is a pseudogene that shares sequence similarity with the functional small integral membrane protein 11 gene (SMIM11). It is catalogued in NCBI Gene (100127905), with reported aliases including C6orf161, FAM165A, and bA33E24.4. There is no evidence in the literature or public databases that SMIM11P1 encodes a functional protein, nor does it possess documented biological roles in cellular or disease processes. Pseudogenes like SMIM11P1 typically arise through genomic duplication or retrotransposition events and generally do not produce active proteins. Unlike some pseudogenes that have regulatory roles or act as biomarkers/disease modifiers, there is currently no evidence for SMIM11P1 involvement in such mechanisms. SMIM11P1 is not listed as a therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), has no known interacting drugs, and lacks any association with safety concerns or therapeutic challenges.
null (no mechanism known; not a target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMIM11 pseudogene 1 (SMIM11P1).